Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: Results of a multicenter 6-week dose-response trial

Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream

Karl R. Beutner, John K. Geisse, Donita Helman et al. · Journal of the American Academy of Dermatology · 1999 · 371 citations

Medicine, Dermatology, Immunology +13

Treatment of genital warts with an immune-response modifier (imiquimod)

Karl R. Beutner, Spotswood L. Spruance, Andrina J. Hougham et al. · Journal of the American Academy of Dermatology · 1998 · 306 citations

Medicine, Dermatology, Immunology +12

Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985–1995: Are primary prevention programs starting to have an effect?

Margaret Staples, Robin Marks, Graham G. Giles · International Journal of Cancer · 1998 · 291 citations · Full text

Medicine, Dermatology, Oncology +17

Trends in non‐melanocytic skin cancer treated in Australia: The second national survey

Robin Marks, Margaret Staples, Graham G. Giles · International Journal of Cancer · 1993 · 279 citations

Medicine, Dermatology, Oncology +13

Intralesional interferon therapy for basal cell carcinoma

Roger C. Cornell, Hubert T. Greenway, Stephen B. Tucker et al. · Journal of the American Academy of Dermatology · 1990 · 204 citations

Medicine, Dermatology, Oncology +10